SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.73-0.2%11:31 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (14250)7/28/2000 10:03:28 AM
From: Robert K.  Read Replies (1) of 17367
 
I think both yours and blues "combo" arguements are possible. Regarding>"I guess the above is more clear, if still you think is apple and oranges then fine with me."
>>my apples & oranges arguement is >is it fair to caompare a 400 trial vs a 1500 trial? If bpi had 1500 in meningo and
zovant had 400 in sepsis would the results be the same or would things be different? You can say zovant works, cause it worked but can you say bpi wont work? Could you say zovant worked if held to the 400 size criteria?
Answer me that Cacaito.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext